Showing results (681-690 of 881) with videos related to

Sort By:
Pageof 89
The Journal of Infectious Diseases|October 4, 2023
Hepatitis C Treatment in People With HIV: Potential to Eliminate Disease and DisparityOluwaseun Falade-Nwulia, Catherine R Lesko, Anthony T Fojo, et al.
Journal of Viral Hepatitis|June 6, 2023
Human immunodeficiency virus coinfection differentially impacts hepatitis B virus viral markers based on hepatitis Be antigen status in patients with suppressed viremiaMauricio Lisker-Melman, Wendy C King, Marc G Ghany, et al.
Journal of Medicinal Chemistry|January 23, 2004
Design, synthesis, and biological evaluation of thio-containing compounds with serum HDL-cholesterol-elevating propertiesHassan Elokdah, Theodore S Sulkowski, Magid Abou-Gharbia, et al.
American Journal of Infection Control|February 26, 2022
Clostridioides difficile infection (CDI) in a previous room occupant predicts CDI in subsequent room occupants across different hospital settingsGeeta Sood, Shaun Truelove, Geoff Dougherty, et al.
Plos Pathogens|April 14, 2023
Architecture of the biofilm-associated archaic Chaperone-Usher pilus CupE from Pseudomonas aeruginosaJan Böhning, Adrian W Dobbelstein, Nina Sulkowski, et al.
Transplantation|June 19, 2018
Changes in Utilization and Discard of HCV Antibody-Positive Deceased Donor Kidneys in the Era of Direct-Acting Antiviral TherapyMary G Bowring, Lauren M Kucirka, Allan B Massie, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 13, 2006
Global transcriptional effects of PEG-IFN-alpha and ribavirin on peripheral blood cells obtained from patients with chronic hepatitis CVijayan Balan, L Aravind, Diane E Grill, et al.
Contemporary Clinical Trials|April 28, 2024
Testing a new model of telehealth-delivered treatment for primary care patients with alcohol use disorder: A randomized controlled trial protocolErin E Bonar, Jason E Goldstick, Matthew J Rostker, et al.
ACG Case Reports Journal|September 22, 2021
Hepatitis B Virus/Hepatitis D Virus-Coinfected Liver Transplant Candidate Receiving Hepatitis B Virus-Deoxyribonucleic Acid-Positive Allograft and Treated With High-Dose Hepatitis B Immune GlobulinMuhammad Baraa Hammami, Ruhail Kohli, Tinsay Woreta, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 23, 2016
Ribavirin-Free Regimen With Sofosbuvir and Velpatasvir Is Associated With High Efficacy and Improvement of Patient-Reported Outcomes in Patients With Genotypes 2 and 3 Chronic Hepatitis C: Results From Astral-2 and -3 Clinical TrialsZobair M Younossi, Maria Stepanova, Mark Sulkowski, et al.
Pageof 89